Propofol
Druganaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1 mainly.
NCT Number: NCT01436799
The investigators hypothesized that both propofol and desflurane would decrease the regional oxygen saturation (rSO2) but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
The investigators hypothesized that both propofol and desflurane would decrease the rSO2 but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position. Therefore, the purpose of this study was to investigate the effect of desflurane and propofol on rSO2 values during the beach chair position for shoulder arthroscopy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
anaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1 mainly.
anaesthesia was maintained by desflurane 4-7vol%
Other names: Des
administration of alfentanil 10 μg kg-1 for anesthetic induction
Other names: alf
administration of rocuronium 0.6 mg kg-1 for anesthetic induction
Other names: roc
Time frame: 1, 3, 5, 7, and 9 min after the beach chair position
definitive values of regional cerebral oxygen saturation(rSO2,%) values are described as mean (SD)
Gachon University Gil Medical Center
Other
International Review Board of Gachon University Gil Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05053932
Anemia, Anemia, Hemolytic
Paris, IDF, France
View Trial DetailsNCT04046484
Acute Stroke, Brain Diseases
Gurgaon, India
View Trial DetailsNCT04437862
Acute Stroke, Brain Diseases
Tampa, Florida, United States
View Trial DetailsNCT02541591
Brain Diseases, Brain Ischemia
Genk, Belgium
View Trial Details